Intelligence » Arthritis » Last Week

Subscribe to get latest posts via email or subscribe to a RSS feed.

Certain occupations linked to an increased risk of rheumatoid arthritis

Wednesday, August 16, 2017 -- New research indicates that certain occupations may put workers at an elevated risk of developing rheumatoid arthritis.

Arthritis on the rise

Tuesday, August 15, 2017 -- The average American today is twice as likely to be diagnosed with knee osteoarthritis than in the years before World War II, Harvard scientists say, but that increase can't be blamed on the reasons...

Rheumatoid Arthritis Predisposes Patients to Heart Disease

Thursday, August 17, 2017 -- Rheumatoid arthritis affects 1% of the population and can cause permanent joint destruction and death. Chronic inflammation associated with rheumatoid arthritis is known to play a role in predisposing patients to heart disease and heart failure.   Mortality caused by rheumatoid arthritis is predominantly due to cardiovascular complications. With 50% of cardiovascular disease associated deaths […] The post Rheumatoid Arthritis Predisposes Patients to Heart Disease appeared first on Medical News Bulletin.

Pfizer's psoriatic arthritis treatment clears advisory committee

Wednesday, August 16, 2017 -- Pfizer Inc.'s proposed dose of tofacitinib for the treatment of adult patients with active psoriatic arthritis (PsA) received recommendation for approval by the U.S. Food and Drug Administration’s Arthritis Advisory Committee (AAC) via a 10-1 vote.The committee provides recommendations to the FDA; the FDA then takes the recommendation into account when deciding whether to approve a drug for U.S. sale and marketing. An FDA decision on whether to approve tofacitinib for PsA should come by December.“Today marks an important positive step in our journey to potentially bring tofacitinib to adult patients living with active psoriatic arthritis and we are pleased with the committee’s positive recommendation based on the favorable benefit:risk profile for tofacitinib,” Michael Corbo, chief development officer of

[Podcast ] Effects of CoQ10 Supplementation on Inflammatory Cytokines and Oxidative Stress in Rheumatoid Arthritis Patients

Tuesday, August 15, 2017 -- Can CoQ10 be a supportive therapeutic for patients with rheumatoid arthritis? Join Dr. Lise Alschuler for this exclusive TAP Integrative podcast as she reviews a double-blind, randomized control trial that used 100mg of CoQ10 daily and measured changes in inflammatory markers in patients with RA. Subscribe to this exclusive audio series on iTunes, Google Play, Stitcher or TuneIn.

6,000-Year-Old Knee Joints Suggest Osteoarthritis Isn't Just Wear And Tear

Tuesday, August 15, 2017 -- American doctors have been noticing an increase in osteoarthritis of the knee. They have suspected two driving forces: more old people and more people who are overweight. A study published in this week's Proceedings of the National Academy of Sciences argues that's far from the whole story. Even correcting for body mass index and age, osteoarthritis of the knee is twice as common now as it was before the 1950s. "That's an incredible difference," says Daniel Lieberman , a professor of human evolutionary biology at Harvard University and co-author of the study. Lieberman started wondering about arthritis a few years ago as he was compiling a list of diseases that modern humans aren't well-adapted to cope with — such

Psoriatic Arthritis Treatment Trends Investigated

Tuesday, August 15, 2017 -- Researchers used claims data between 2004-2015 from a large commercial database to identify patients with psoriatic arthritis who were initiated on DMARDs.

Cork firm tests raspberry as treatment for arthritis

Thursday, August 17, 2017 -- A leading clinical trials company in Cork is examining whether fish and raspberry extracts offer a long-term treatment for osteoarthritis.

Knee Arthritis Rates Have Doubled, But Scientists Can’t Figure Out Why

Tuesday, August 15, 2017 -- A new study finds that rates of knee arthritis are rising in America, but we're not sure why.

Oral Glucosamine Found No More Effective Than Placebo For Osteoarthritis Pain

Wednesday, August 16, 2017 -- Interview with: Jos Runhaar, PhD Erasmus MC Department of General Practice Rotterdam The Netherlands What is the background for this study? What are the main findings? Response: Most international guidelines report an overall lack of efficacy of glucosamine … Continue reading →

Study of Cannabinoid Drug for Osteoarthritis Continues Even After Failed Phase 2 Trial

Wednesday, August 16, 2017 -- NewsZynerba Pharmaceuticals announces that results from Phase 2 STOP trial support continued development of ZYN002 in osteoarthritis.Contributed Author: Zynerba PharmaceuticalsTopics: Drug Development